Claudio Cerchione

InstitutionHematology Unit
AddressForlì-Cesena
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 2 publications in December 2020
    All Publications
    Bar chart showing 25 publications over 7 distinct years, with a maximum of 8 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rossi A, Prochowski Iamurri A, Cerchione C, Gentili N, Danesi V, Altini M, Paganelli G, Barone D. Radiology imaging management in an Italian cancer center (IRST IRCCS) during the COVID-19 pandemic. Insights Imaging. 2020 Dec 03; 11(1):129. PMID: 33270166.
      Citations: 2   Article has an altmetric score of 1    
    2. Monti M, Vertogen B, Masini C, Donati C, Lilli C, Zingaretti C, Musuraca G, De Giorgi U, Cerchione C, Farolfi A, Cortesi P, Viale P, Martinelli G, Nanni O. Hydroxychloroquine as Prophylaxis for COVID-19: A Review. Front Pharmacol. 2020; 11:605185. PMID: 33343376.
      Citations: 2   Article has an altmetric score of 10    
    3. Lucchesi A, Silimbani P, Musuraca G, Cerchione C, Martinelli G, Di Carlo P, Napolitano M. Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease. J Med Virol. 2021 01; 93(1):124-126. PMID: 32579244.
      Citations: 7   Fields:    Translation:Humans
    4. Ravaioli S, Tebaldi M, Fonzi E, Angeli D, Mazza M, Nicolini F, Lucchesi A, Fanini F, Pirini F, Tumedei MM, Cerchione C, Viale P, Sambri V, Martinelli G, Bravaccini S. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients. Cell Transplant. 2020 Jan-Dec; 29:963689720968749. PMID: 33108902.
      Citations: 5   Article has an altmetric score of 2    Fields:    Translation:HumansCellsPHPublic Health
    5. Schepisi G, Cursano MC, Casadei C, Menna C, Altavilla A, Lolli C, Cerchione C, Paganelli G, Santini D, Tonini G, Martinelli G, De Giorgi U. CAR-T cell therapy: a potential new strategy against prostate cancer. J Immunother Cancer. 2019 10 16; 7(1):258. PMID: 31619289.
      Citations: 13   Article has an altmetric score of 22    Fields:    Translation:HumansCells
    6. Cerchione C, Nappi D, Pareto AE, Romano A, Martinelli V, Picardi M, Pane F, Catalano L. Lenalidomide at the dose of 25?mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience. Anticancer Drugs. 2018 04; 29(4):371-372. PMID: 29420336.
      Fields:    Translation:Humans
    7. Cerchione C, Nappi D, Pareto AE, Di Perna M, Zacheo I, Picardi M, Pane F, Catalano L. Safety and comfort of domestic bortezomib injection in real-life experience. Support Care Cancer. 2018 Sep; 26(9):3111-3116. PMID: 29574618.
      Citations: 1   Fields:    Translation:Humans
    8. Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M. Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography. Support Care Cancer. 2018 06; 26(6):1691-1694. PMID: 29523967.
      Citations: 2   Article has an altmetric score of 1    Fields:    
    9. Romano A, Parrinello NL, Vetro C, Chiarenza A, Cerchione C, Ippolito M, Palumbo GA, Di Raimondo F. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy. Ann Hematol. 2018 Jun; 97(6):1009-1018. PMID: 29442162.
      Citations: 15   Article has an altmetric score of 1    Fields:    Translation:HumansCells
    10. Mondello P, Steiner N, Willenbacher W, Cerchione C, Nappi D, Mauro E, Ferrero S, Cuzzocrea S, Mian M. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study. Oncologist. 2018 04; 23(4):454-460. PMID: 29317554.
      Citations: 6   Article has an altmetric score of 24    Fields:    Translation:Humans
    11. Romano A, Laura Parrinello N, Cerchione C, Letizia Consoli M, Parisi M, Calafiore V, Martino E, Conticello C, Di Raimondo F, Alberto Palumbo G. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents. Blood Cancer J. 2017 12 15; 7(12):649. PMID: 29242558.
      Citations: 16   Fields:    Translation:HumansCells
    12. Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Raimondo M, Di Perna M, Troncone G, Ciancia G, Intrieri M, Pane F. Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma. Br J Haematol. 2018 09; 182(5):715-718. PMID: 28737231.
      Citations: 2   Fields:    Translation:HumansCells
    13. Pugliese N, Salvatore P, Iula DV, Catania MR, Chiurazzi F, Della Pepa R, Cerchione C, Raimondo M, Giordano C, Simeone L, Caruso S, Pane F, Picardi M. Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia. Cancer Med. 2017 Jul; 6(7):1500-1511. PMID: 28556623.
      Citations: 4   Fields:    Translation:Humans
    14. Cerchione C, Maraolo AE, Marano L, Pugliese N, Nappi D, Tosone G, Cimmino I, Cozzolino I, Martinelli V, Pane F, Picardi M. Secondary syphilis mimicking malignancy: A case report and review of literature. J Infect Chemother. 2017 Aug; 23(8):576-578. PMID: 28456488.
      Citations: 2   Article has an altmetric score of 1    Fields:    Translation:Humans
    15. Cerchione C, Nappi D, Di Perna M, Zacheo I, Migliaccio I, Salvatore D, Picardi M, Pane F, Catalano L. A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide. Clin Case Rep. 2017 Apr; 5(4):505-507. PMID: 28396778.
      Citations: 1   
    16. Cerchione C, Peluso I, Nappi D, Pareto AE, Picardi M, Martinelli V, Pane F. Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis. Ann Hematol. 2017 04; 96(4):697-699. PMID: 28197723.
      Citations: 4   Fields:    Translation:Humans
    17. Della Pepa R, Pagano L, Cerchione C, Pugliese N, Pane F, Picardi M. Reply to the letter to the editor "chronic disseminated candidiasis" by Kenneth Rolston. Support Care Cancer. 2017 04; 25(4):1045-1046. PMID: 28091755.
      Fields:    Translation:Humans
    18. Fiore M, Maraolo AE, Chiodini P, Cerchione C, Gentile I, Borgia G, Pace MC. Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review. Cardiovasc Hematol Disord Drug Targets. 2017; 17(2):105-110. PMID: 28676032.
      Citations: 2   Fields:    Translation:Humans
    19. Cerchione C, De Renzo A, Di Perna M, Della Pepa R, Pugliese N, Catalano L, Pane F, Picardi M. Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience. Support Care Cancer. 2017 03; 25(3):839-845. PMID: 27812763.
      Citations: 8   Article has an altmetric score of 1    Fields:    Translation:Humans
    20. Cerchione C, Nappi D, Di Perna M, Zacheo I, Pareto AE, Picardi M, Catalano L, Pane F. Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma. Case Rep Hematol. 2016; 2016:6745286. PMID: 27867671.
      Citations: 1   
    21. Cerchione C, Cerciello G, Avilia S, Della Pepa R, Pugliese N, Picardi M, Catalano L, Pane F. Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease. Blood Transfus. 2018 01; 16(1):32-35. PMID: 27893351.
      Fields:    Translation:Humans
    22. Cerchione C, Catalano L, Peluso I, Nappi D, Di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F. Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone. Support Care Cancer. 2016 12; 24(12):4835-4837. PMID: 27726031.
      Citations: 7   Article has an altmetric score of 4    Fields:    
    23. Cerchione C, Lucignano M, Pane F, Catalano L. Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al. Eur J Haematol. 2016 May; 96(5):544. PMID: 26589779.
      Citations: 3   Fields:    Translation:Humans
    24. Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study. Clin Nucl Med. 2015 Apr; 40(4):303-8. PMID: 25608167.
      Citations: 9   Article has an altmetric score of 4    Fields:    Translation:Humans
    25. Cerchione C, Catalano L, Pareto AE, Picardi M, Pane F. Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience. Support Care Cancer. 2015 Feb; 23(2):301-2. PMID: 25341551.
      Citations: 7   Fields:    Translation:HumansPHPublic Health
    26. Cerchione C, Catalano L, Cerciello G, Avilia S, Picardi M, Risitano AM, Pisano I, Alfinito F, Pane F. Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA). Ann Hematol. 2015 Mar; 94(3):531-4. PMID: 25135452.
      Citations: 5   Fields:    Translation:HumansCells